论文部分内容阅读
目的观察酚妥拉明联合硫酸镁治疗小儿喘憋性肺炎的临床疗效。方法将符合诊断标准的130例小儿喘憋性肺炎患儿随机分为治疗组(65例)和对照组(65例),两组患儿均给予常规治疗,在此基础上治疗组加用酚妥拉明及硫酸镁,酚妥拉明为每次0.10~0.15 mg/kg,25%硫酸镁0.10~0.15 ml/kg,加入5%或10%葡萄糖液30ml中,应用微量注射泵静脉推注,泵速为15~20 ml/h,每日2次,连用3~5 d。结果总有效率治疗组为96.9%,对照组为69.2%,差异有统计学意义(P<0.01);临床表现缓解时间、住院时间治疗组与对照组比较差异有统计学意义(P<0.01)。结论酚妥拉明联合硫酸镁治疗小儿喘憋性肺炎临床观察疗效好,不良反应小。
Objective To observe the clinical efficacy of phentolamine combined with magnesium sulfate in children with asthmatic pneumonia. Methods Thirty children with asthmatic pneumonia were randomly divided into treatment group (65 cases) and control group (65 cases), both groups were given routine treatment. On the basis of this, the treatment group was treated with phenol Troplatin and magnesium sulfate, phentolamine 0.10 ~ 0.15 mg / kg each time, 25% magnesium sulfate 0.10 ~ 0.15 ml / kg, adding 5% or 10% glucose solution 30ml, , Pump speed of 15 ~ 20 ml / h, 2 times a day, once every 3 ~ 5 d. Results The total effective rate was 96.9% in the treatment group and 69.2% in the control group, the difference was statistically significant (P <0.01). The clinical manifestation relief time and hospitalization time had significant difference between the treatment group and the control group (P <0.01) . Conclusion Phentolamine combined with magnesium sulfate in the treatment of children with asthmatic pneumonia clinical observation of good efficacy, adverse reactions.